Evidence map›Paper›PMID 33096317›Full record

ReviewRespiratory medicine

Aquaporins in lung health and disease: Emerging roles, regulation, and clinical implications.

Ekta Yadav, Niket Yadav, Ariel Hus, Jagjit S Yadav

Open access · bronzeAbstract readReview
In one paragraph

Review in Respiratory medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 66 citations in OpenAlex.

  1. Dexmedetomidine Dose-Dependent Modulation of Lung Function and AQP1 Expression During One-Lung Ventilation in Adults Undergoing Thoracoscopic Surgery.Medical science monitor : international medical journal of experimental and clinical research · 2025
    Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Research Progress on the Mechanisms of High Mucus Secretion in the Airway: A Scoping Review.International journal of chronic obstructive pulmonary disease · 2026
    Article
  9. Article
  10. Aquaporins: a novel perspective in the treatment of lung diseases.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2025
    Review
  11. Article
  12. Article
  13. Article
  14. Pre-Existing Diabetes Alters Pulmonary Inflammatory Gene Expression Priming for Injury.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  15. Aquaporins in Allergic Response: A New Player.Clinical reviews in allergy & immunology · 2025
    Review
  16. [Protective effect ofNan fang yi ke da xue xue bao = Journal of Southern Medical University · 2025
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 1 country.

Ekta YadavDepartment of Physiology and Biophysics, Case Western Reserve University School of Medicine, Cleveland, OH, 44106, USA. Electronic address: Exy57@case.edu.
Niket YadavMedical Scientist Training Program, University of Virginia School of Medicine, Charlottesville, VA, 22908-0738, USA.
Ariel HusDepartment of Biology, University of Miami, Coral Gables, Florida, 33146, USA.
Jagjit S YadavDepartment of Environmental and Public Health Sciences, University of Cincinnati College of Medicine, Cincinnati, OH, 45267, USA. Electronic address: jagjit.yadav@uc.edu.
Case Western Reserve University · USUniversity of Cincinnati Medical Center · USUniversity of Miami · USUniversity of Virginia · US

Funding

REPRODUCTIVE AND DEVELOPMENTAL TOXICOLOGY RESEARCHP30ES006096 · NIEHS · UNIVERSITY OF CINCINNATI · PI PINNEY, SUSAN MENGEL · 1992 to 2022
$35.4M
NIEHS NIH HHS P30 ES006096
6 · The paper itself

Abstract

Aquaporins (AQPs) aka water channels are a family of conserved transmembrane proteins (~30 kDa monomers) expressed in various organ systems. Of the 13 AQPs (AQP0 through AQP12) in the human body, four (AQPs 1, 3, 4, and 5) are expressed in the respiratory system. These channels are conventionally known for mediating transcellular fluid movements. Certain AQPs (aquaglyceroporins) have the capability to transport glycerol and potentially other solutes. There is an emerging body of literature unveiling the non-conventional roles of AQPs such as in cell proliferation and migration, gas permeation, signal potentiation, etc. Initial gene knock-out studies established a physiological role for lung AQPs, particularly AQP5, in maintaining homeostasis, by mediating fluid secretion from submucosal glands onto the airway surface liquid (ASL) lining. Subsequent studies have highlighted the functional significance of AQPs, particularly AQP1 and AQP5 in lung pathophysiology and diseases, including but not limited to chronic and acute lung injury, chronic obstructive pulmonary disease (COPD), other inflammatory lung conditions, and lung cancer. AQP1 has been suggested as a potential prognostic marker for malignant mesothelioma. Recent efforts are directed toward exploiting AQPs as targets for diagnosis, prevention, intervention, and/or treatment of various lung conditions. Emerging information on regulatory pathways and directed mechanistic research are posited to unravel novel strategies for these clinical implications. Future considerations should focus on development of AQP inhibitors, blockers, and modulators for therapeutic needs, and better understanding the role of lung-specific AQPs in inter-individual susceptibility to chronic lung diseases such as COPD and cancer.

Indexed as

Acute Lung InjuryAnimalsAquaporin 1Aquaporin 5AquaporinsBody FluidsCell MovementCell ProliferationDisease Models, AnimalDisease SusceptibilityGlycerolHumansLungLung NeoplasmsMice, KnockoutPneumoniaAQP1 protein, humanAQP5 protein, humanAquaporin 1Aquaporin 5AquaporinsGlycerolAcute lung injuryAquaporinsChronic obstructive pulmonary diseaseLung cancerLung inflammationLung pathophysiologyRegulation

Identifiers

PMID33096317
PMCPMC7733530
OpenAlexW3094151058

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.